[1]
Lacambra, M.G. et al. 2024. Renal Adverse Reaction Secondary to Check-point Inhibitors in Metastatic Renal Cancer.
Journal of Clinical Nephrology
. 8, 2 (May 2024), 076–077. DOI:https://doi.org/10.29328/journal.jcn.1001130.